Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1 or 2 mutation
Crossref DOI link: https://doi.org/10.1007/s10198-017-0887-5
Published Online: 2017-04-05
Published Print: 2018-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Müller, Dirk
Danner, Marion
Rhiem, Kerstin
Stollenwerk, Björn
Engel, Christoph
Rasche, Linda
Borsi, Lisa
Schmutzler, Rita
Stock, Stephanie
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (NKP-332-019)
License valid from 2017-04-05